Logo

    Genetic Testing Among Women with Breast Cancer Increasing, Can Impact Treatment Decisions

    enFebruary 11, 2016
    What was the main topic of the podcast episode?
    Summarise the key points discussed in the episode?
    Were there any notable quotes or insights from the speakers?
    Which popular books were mentioned in this episode?
    Were there any points particularly controversial or thought-provoking discussed in the episode?
    Were any current events or trending topics addressed in the episode?

    About this Episode

    [Read the Article]

    Rates of genetic testing for BRCA1 and BRCA2 mutations have increased among younger women diagnosed with breast cancer, according to a new study. The study focused on nearly 900 women diagnosed with breast cancer at age 40 or younger. Researchers looked at rates of genetic testing, barriers to testing, and how the test results affected treatment decisions.

    In 2006, the rates of BRCA testing were in the seventy percent range and by 2012 that proportion rose to ninety-five percent. While the majority of women reported being tested for BRCA 1 and 2, many were not, and a small minority reported that no one had discussed genetic risk or testing options. The study authors note that the overall goal of genetic testing is to help women make informed treatment decisions. Assessment of a young woman's genetic risk after a breast cancer diagnosis can affect treatment decisions and the results can also have health implications for her relatives.

    [Watch more videos of The JAMA Report]

    Recent Episodes from Video Library

    2020 Crohn’s & Colitis Congress: Key Takeaways for APPs & RNs

    2020 Crohn’s & Colitis Congress: Key Takeaways for APPs & RNs
    Host: Matt Birnholz, MD
    Guest: Kimberly Kearns, NP

    An advanced practice-provider’s role in treating patients with IBD is very critical, especially at a time when emerging data supports the multidisciplinary team’s positive impact on patients' experiences. Joining Dr. Matt Birnholz is nurse practitioner Kimberly Kearns to illuminate the impact advanced practice-providers have on patient outcomes.

    2020 Crohn’s & Colitis Congress: IBD Care Outside the Gut

    2020 Crohn’s & Colitis Congress: IBD Care Outside the Gut
    Host: Matt Birnholz, MD
    Guest: James D. Lewis, MD, MSCE

    The recipe for a healthy gut involves much more than just prescribing medications and diet restrictions. Treating the whole patient by identifying malnourishment, dermatologic conditions, and psychosocial needs can help ensure that IBD doesn’t have any negative impacts beyond the gut. Join Dr. Matt Birnholz as he digests the highlights from the 2020 Crohn's and Colitis Congress session "IBD: Beyond the Gut" with guest Dr. James Lewis.

    2020 Crohn’s & Colitis Congress: Research Takeaways

    2020 Crohn’s & Colitis Congress: Research Takeaways
    Host: Matt Birnholz, MD
    Guest: Maria T. Abreu, MD

    As emerging data supports the idea that patients with IBD can be managed by focusing on the microbiome, discussing dietary needs, and using cognitive behavioral therapy, it’s important that providers are attentive to the changing paradigms. During the 2020 Crohn’s and Colitis Foundation Congress, Dr. Maria Abreu leverages her triple-threat perspective on bench research, clinical research, and clinical care to share how we can improve care for patients with IBD.

    2020 Crohn’s & Colitis Congress: Pain, Fatigue, & Nutrition in IBD

    2020 Crohn’s & Colitis Congress: Pain, Fatigue, & Nutrition in IBD
    Host: Matt Birnholz, MD
    Guest: Tiffany H. Taft, PsyD

    Since the brain-gut connection directly impacts the biopsychosocial well-being of IBD patients, Dr. Matt Birnholz sits down with Dr. Tiffany Taft, Director of Psychogastroenterology Research in the Division of Gastroenterology and Hepatology at Northwestern University, to discuss how integrating psychogastroenterology principles and techniques into your practice can help alleviate the burden of IBD on your patients.

    2020 Crohn’s & Colitis Congress: Explaining Risk to Patients

    2020 Crohn’s & Colitis Congress: Explaining Risk to Patients
    Host: Matt Birnholz, MD
    Guest: Corey A. Siegel, MD, MS

    At the third annual Crohn’s & Colitis Congress in Austin, Texas, Co-Director of the IBD Program and Section Chief of Gastroenterology and Hepatology at the Dartmouth-Hitchcock Medical Center Dr. Corey Siegel sat down with Dr. Matt Birnholz to share his approach to presenting risk data to his IBD patients.

    A Pre-Teen’s Perspective on Living with IBD

    A Pre-Teen’s Perspective on Living with IBD
    Host: Jennifer Caudle, DO

    To gain more insights into how inflammatory bowel disease (IBD) affects our young patients, Dr. Jennifer Caudle connects with Caroline, a 12-year-old patient who was diagnosed with IBD at the age of 4, and her parents, Preston and Rachelle, about the challenges they face and the strategies and solutions available that can help children and teens like Caroline manage this condition.

    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io